Sequencing and Genomic Technologies (SGT) is a basic science research core affiliated with the Duke Cancer Institute (DCI) that offers a full range of state-of-the-art genomic services. For answers to common questions, please visit our Frequently Asked Questions page.
Director Devi Swain Lenz is available for project consultations.
News & Announcements
IT Infrastructure Update
The Sequencing and Genomic Technologies is undergoing an update to our IT infrastructure to support the larger datasets produced by the Illumina X Plus and PacBio Revio.
There have been some bugs that have affected data delivery of all sequencers. We are working diligently to resolve the IT issues.
There may be delays in data delivery in the next few weeks. We appreciate your understanding and your support of SGT.
Genome Academy Course Announced: Introduction to DNA Sequencing
Introduction to DNA Sequencing
Instructor: Devi Swain Lenz, PhD
Date and Time: March 20, 1-2 PM
Location: 2240 CIEMAS
Job Posting: Lab Research Analyst
The Sequencing and Genomic Technologies Core Facility has an opening for a Lab Research Analyst.
Sarah Clarke embarks on a new journey
Sarah Clarke has served as a lab research analyst in the Sequencing and Genomic Technologies (SGT) core facility since 2020. In January, she will be transitioning to a new position at the NC State Vector-Borne Disease Lab. She received her undergraduate degree in natural resource ecology from the University of Vermont in 2020.
How did you arrive at this position at Duke?
Holiday Hours & Closures
The Sequencing and Genomic Technologies Core Facility will be closed and will not be accepting samples on the following dates:
- November 23 - 24
- December 22 - January 2
Sequencing Core launches Illumina X Plus sequencer
The Sequencing and Genomics Technologies Core Facility is running orders for the Illumina NovaSeq X Plus.
The X Plus provides high quality short read sequences for a fraction of the cost of the Illumina NovaSeq 6000. Additionally custom read-length projects can now purchase lanes instead of full flow cells (e.g. 75 SR for miRNA-seq, single cell protocols).
The available products are listed below, with more read options available towards the end of the year.
|
Product |
SGT gives tour of Chesterfield on Halloween
Devi Swain Lenz “expressed herself” as Madonna during a new faculty tour of the Sequencing and Genomic Technologies Core facility on Halloween. They explored the Chesterfield Building, home to Duke's long-read sequencing for examining genome regions and short-read sequencers vital for cancer research.
The Long and the Short of It: New sequencing capabilities in the Sequencing & Genomic Technologies Core Facility
The Sequencing and Genomic Technologies (SGT) core facility has added two new sequencers to the lab: the PacBio Revio long-read sequencer and the Illumina NovaSeq X Plus short-read sequencer.
PacBio Revio Launch Party
The Sequencing and Genomic Technologies Core Facility will host a launch party for the new PacBio Revio long-read sequencer.
Agenda: